Goodbye CTD555... when you exit like this you have
Post# of 148166
As for me... the science hasn’t changed and the drug will be approved for a minimum of two indications. Covid and HIV. Why? Because the end point in the new trial has been met already in CD-12. The end point in HIV has been met also. This has derisked my investment in my eyes. I am not going anywhere. I am a believer in the science and look for more than just the two BLA’s I feel are already in the bag.
Happy journeys to you CTD555. No reply needed...